Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Optimizing your budget with zero-based techniques can significantly improve cash flow. Explore methods that work for you.
23,484 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
A convincing AI-generated video allegedly featuring a real leader drew an 86-year-old into a crypto scam, draining ne...
Bitcoin has tumbled from its peak while gold shines in volatile times. Could a monster rally lift BTC to $150,000 by ...
A flurry of news sent Kymera Therapeutics stock popping this week. From trial milestones to new price targets and ins...
Markets tremble as Iran’s leadership shift and rising oil force volatility. A JPMorgan strategist cautions against qu...
July can be a pivotal moment for travel stocks. Here are three clear reasons why Carnival stock may deserve a place o...
BioNTech’s stock is under pressure as investors react to weak guidance and leadership pivots. This deep dive breaks d...
Choosing the right pharmaceutical ETF can feel like balancing income with growth. This guide compares VanEck's PPH an...
Freedom isn’t just a moral goal—it’s a practical investing lens. This guide explains how atm: money: investing freedo...
The S&P 500 kicked off 2026 with a strong first half, delivering solid gains. This article breaks down what that coul...
A seasoned investor warns that the global financial system faces a new kind of threat: capital shifts driven by debt,...
Markets keep climbing amid strong earnings and AI-led investment. This article explains why this bull market crushing...